Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Animal models indicate that the antimicrobial peptide hepcidin (HAMP; OMIM 606464) is probably a key regulator of iron absorption in mammals. Here we report the identification of two mutations (93delG and 166C-->T) in HAMP on 19q13 in two families with a new type of juvenile hemochromatosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficits in hepcidin-mediated regulation of FPN, often due to hereditary hemochromatoses, lead to iron overload and widespread tissue damage affecting the liver, heart, pancreas, and joints 11-13 .”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [11]
In the citing paper
“There is a single human hepcidin gene whose essential role in iron homeostasis was confirmed by identifying homozygous frameshift or nonsense mutations in affected individuals with severe juvenile hemochromatosis”
From IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin (2004) · cites this paper as [9]
In the citing paper
“HAMP‐deficient mice and humans present with a severe iron loading phenotype, and injection of synthetic HAMP decreases serum iron concentrations. 39 , 40 , 41”
From The battle for iron in enteric infections (2020) · cites this paper as [40]
In the citing paper
“First, mutations in the hepcidin gene itself (called HAMP) cause hemochromatosis by preventing the production of functional hepcidin protein.161”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [161]
In the citing paper
“In iron-replete cells, IRP1, which has ∼30% homology to mitochondrial aconitase based on amino acid alignments, loses its affinity for the IRE, and converts to a cytosolic aconitase (127, 263).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [263]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Self-citationWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13468 · Cited by 561
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113468 · Cited by 557
Cited by
Items 101–200 of 869
Influence of Iron on Bone Homeostasis
Balogh, E., Paragh, G., & Jeney, V. (2018) · Pharmaceuticals · doi:10.3390/ph11040107 · Cited by 184
“Mutations of transferrin receptor-2 gene (TfR2) [31], hemojuvelin gene (HJV) [32], hepcidin gene (HAMP) [33] and the ferroportin gene (SCL40A1) [34] contribute to less frequent forms of hereditary hemochromatosis.”
BackgroundHemochromatosis classification: update and recommendations by the BIOIRON Society
Girelli, D., Busti, F., Brissot, P., Cabantchik, I., Muckenthaler, M. U., & Porto, G. (2022) · Blood · doi:10.1182/blood.2021011338 · Cited by 187
Self-citationIron homeostasis: An anthropocentric perspective
Coffey, R., & Ganz, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.781823 · Cited by 188
Détivaud, L., Nemeth, E., Boudjema, K., Turlin, B., Troadec, M.-B., Leroyer, P., Ropert, M., Jacquelinet, S., Courselaud, B., Ganz, T., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4855 · Cited by 194
A Systems Biology Approach to Iron Metabolism
Chifman, J., Laubenbacher, R., & Torti, S. V. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-2095-2_10 · Cited by 167
“A severe and less common form of HH, with extremely low or absent hepcidin levels, is juvenile hemochromatosis (mutations in HJV or HAMP genes) that leads to hypogonadism, heart failure, and death [65–67].”
BackgroundRegulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages
Liu, X.-B., Nguyen, N.-B. H., Marquess, K. D., Yang, F., & Haile, D. J. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2005.04.006 · Cited by 180
Sun, C. C., Vaja, V., Babitt, J. L., & Lin, H. Y. (2012) · American Journal of Hematology · doi:10.1002/ajh.23110 · Cited by 185
“Furthermore, patients with very rare mutations in hepcidin itself have a severe early-onset form of this disease [33].”
BackgroundSpectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
Lanzara, C. (2004) · Blood · doi:10.1182/blood-2004-01-0192 · Cited by 185
The liver: conductor of systemic iron balance
Meynard, D., Babitt, J. L., & Lin, H. Y. (2014) · Blood · doi:10.1182/blood-2013-06-427757 · Cited by 177
New insights into iron regulation and erythropoiesis
Kim, A., & Nemeth, E. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000132 · Cited by 171
“Conversely, inactivation of the hepcidin gene in mice caused severe iron overload [10,11], and mutations in the hepcidin gene in humans are associated with juvenile hemochromatosis, a particularly severe form of genetic iron overload [12].”
BackgroundHepcidin inhibits apical iron uptake in intestinal cells
Mena, N. P., Esparza, A., Tapia, V., Valdés, P., & Núñez, M. T. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00122.2007 · Cited by 175
“Iron loading induces Hepc upregulation in mice (21), and mutations in the Hepc gene produce severe juvenile hemochromatosis (22).”
Background“Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels
Nairz, M., Theurl, I., Swirski, F. K., & Weiss, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1944-8 · Cited by 178
“Hepcidin Hepcidin antimicrobial peptide HAMP Binds to FPN1 to label it for internalization and degradation; induced by IL-6, IL-22 and Bmp6 [6, 7, 172]; genetic defect results in juvenile hemochromatosis (type 2B) [174, 194]”
BackgroundRegulation of Hepcidin and Iron-Overload Disease
Lee, P. L., & Beutler, E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092205 · Cited by 174
“In human studies, some cases of juvenile hemochromatosis were found to be the result of HAMP mutations (10).”
BackgroundMerle, U., Fein, E., Gehrke, S. G., Stremmel, W., & Kulaksiz, H. (2007) · Endocrinology · doi:10.1210/en.2006-1331 · Cited by 173
Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss
Jeney, V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00077 · Cited by 163
“, 2004), hepcidin gene (HAMP) (Roetto et al., 2003), and the ferroportin gene (SCL40A1) (Pietrangelo, 2004).”
BackgroundJacolot, S., Le Gac, G., Scotet, V., Quere, I., Mura, C., & Ferec, C. (2004) · Blood · doi:10.1182/blood-2003-10-3366 · Cited by 165
Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo
Soe-Lin, S., Apte, S. S., Andriopoulos, B., Andrews, M. C., Schranzhofer, M., Kahawita, T., Garcia-Santos, D., & Ponka, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900808106 · Cited by 167
“A loss of hepcidin gene expression in both mice and humans results in iron overload (18, 19), whereas an excess of hepcidin gene expression in mice results in severe iron-deficiency anemia (20, 21).”
BackgroundHepcidins in amphibians and fishes: Antimicrobial peptides or iron-regulatory hormones?
Shi, J., & Camus, A. C. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2005.10.009 · Cited by 164
“It has been reported that HAMP mutations can cause juvenile hemochromatosis in the homozygous state [17].”
BackgroundFinberg, K. E., Whittlesey, R. L., Fleming, M. D., & Andrews, N. C. (2010) · Blood · doi:10.1182/blood-2009-05-224808 · Cited by 164
Ganz, T. (2004) · Current Opinion in Hematology · doi:10.1097/00062752-200407000-00004 · Cited by 166
Review article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162
“Type 2B is due to mutation in the hepcidin (HAMP) gene on chromosome 19 (19q31).(55) HJV is expressed in the liver, heart”
BackgroundDeletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Nai, A., Pagani, A., Mandelli, G., Lidonnici, M. R., Silvestri, L., Ferrari, G., & Camaschella, C. (2012) · Blood · doi:10.1182/blood-2012-01-401885 · Cited by 161
Self-citationIroning out mechanisms of iron homeostasis and disorders of iron deficiency
Koleini, N., Shapiro, J. S., Geier, J., & Ardehali, H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148671 · Cited by 171
First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin
Wallace, D. F., Summerville, L., Lusby, P. E., & Subramaniam, V. N. (2005) · Gut · doi:10.1136/gut.2004.062018 · Cited by 160
“This differs from humans and rats which only have one gene. Mutations of hepcidin in humans and knockout in mice lead to a severe form of haemochromatosis.”
BackgroundShike, H. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2003.11.009 · Cited by 158
Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin
González, A. S., Bellido, D., Soto, M. B., Pértega-Díaz, S., Olmos, M. Á. M., & Vidal, O. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602384 · Cited by 176
“It has also been suggested that iron accumulation can be triggered by MS and/or genetic factors through the development of steatosis (Roetto et al., 2003; Den Boer et al., 2004; Robson et al., 2004), which might alter hepatic production of hepcidin, a protein that regulates central iron metabolism by modulating either…”
Genetics of primary sclerosing cholangitis and pathophysiological implications
Jiang, X., & Karlsen, T. H. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.154 · Cited by 155
Lactoferrin: Role in iron homeostasis and host defense against microbial infection
Ward, P. P., & Conneely, O. M. (2004) · BioMetals · doi:10.1023/b:biom.0000027693.60932.26 · Cited by 169
“Furthermore, mutation of the human hepcidin gene was recently shown to be a causative agent of juvenile hemochromatosis (Roetto et al. 2003).”
BackgroundCardiac Involvement in Hemochromatosis
Gulati, V., Harikrishnan, P., Palaniswamy, C., Aronow, W. S., Jain, D., & Frishman, W. H. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e3182a67805 · Cited by 159
“Most cases of hemochromatosis result from reduced activity or decreased synthesis of hepcidin. this may be due to mutations in the HAMP gene or alterations in the genes that regulate hepcidin synthesis, such as the HFE gene (mutated in more than 80% of cases of hemochromatosis), TfR2, or HJV.19 Reduction in hepcidin l…”
BackgroundHepcidin--a peptide hormone at the interface of innate immunity and iron metabolism.
Ganz, T. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-29916-5_7 · Cited by 160
Verga Falzacappa, M. V., Casanovas, G., Hentze, M. W., & Muckenthaler, M. U. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0313-7 · Cited by 146
Sham, R. L., Phatak, P. D., West, C., Lee, P., Andrews, C., & Beutler, E. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2004.12.002 · Cited by 146
“Juvenile hemochromatosis with an early age of onset has been associated with mutations in either the hemojuvelin gene on chromosome 1q [6], or the HAMP gene [7].”
BackgroundJuvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes
Pietrangelo, A., Caleffi, A., Henrion, J., Ferrara, F., Corradini, E., Kulaksiz, H., Stremmel, W., Andreoné, P., & Garuti, C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.057 · Cited by 151
Hemochromatosis: Genetics and Pathophysiology
Beutler, E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131310 · Cited by 144
Knisely, A. S., Magid, M. S., Dische, M. R., & Cutz, E. (1987) · PubMed · Cited by 141
Porto, G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4707 · Cited by 140
Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin
Lee, P. L., Beutler, E., Rao, S. V., & Barton, J. C. (2004) · Blood · doi:10.1182/blood-2004-01-0072 · Cited by 139
The RGM/DRAGON family of BMP co-receptors
Corradini, E., Babitt, J. L., & Lin, H. Y.-F. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.008 · Cited by 153
“Patients with mutations in the HJV gene share the same phenotype as that of patients with mutations that disrupt the gene encoding hepcidin [74].”
Iron Imports. I. Intestinal iron absorption and its regulation
Frazer, D. M., & Anderson, G. J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00220.2005 · Cited by 139
“The demonstration that hepcidin is the principal molecule regulating absorption (23) and the finding that it interacts with ferroportin 1 (14), which is only expressed in mature enterocytes, provide very strong evidence that signals from the body can be detected by mature villus enterocytes.”
BackgroundIntestinal Ferritin H Is Required for an Accurate Control of Iron Absorption
Vanoaica, L., Darshan, D., Richman, L., Schümann, K., & Kühn, L. C. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.003 · Cited by 137
Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin
Pietrangelo, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.045 · Cited by 136
Hepcidin and the BMP-SMAD pathway: An unexpected liaison
Silvestri, L., Nai, A., Dulja, A., & Pagani, A. (2019) · Vitamins and Hormones · doi:10.1016/bs.vh.2019.01.004 · Cited by 124
Functional consequences of ferroportin 1 mutations
Liu, X.-B., Yang, F., & Haile, D. J. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.04.005 · Cited by 156
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis
Ramsay, A. J., Hooper, J. D., Folgueras, A. R., Velasco, G., & López-Otín, C. (2009) · Haematologica · doi:10.3324/haematol.2008.001867 · Cited by 143
“Consistently, mice deficient in hepcidin(82) and humans with mutations of this gene develop severe iron overload disorders.(83) Conversely, mice with increased transgenic expression of hepcidin in the liver manifest severe iron deficiency anemia.”
BackgroundThe Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism
Fleming, M. D. (2008) · Hematology · doi:10.1182/asheducation-2008.1.151 · Cited by 153
Pancreatic β-cells express hepcidin, an iron-uptake regulatory peptide
Kulaksiz, H., Fein, E., Redecker, P., Stremmel, W., Adler, G., & Cetin, Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0528 · Cited by 154
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice
Meynard, D., Vaja, V., Sun, C. C., Corradini, E., Chen, S., López-Otín, C., Grgurević, L., Hong, C. C., Stirnberg, M., Gütschow, M., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348698 · Cited by 143
Current approach to hemochromatosis
Brissot, P., Troadec, M., Bardou‐Jacquet, E., Lan, C. L., Jouanolle, A., Deugnier, Y., & Loréal, O. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.03.001 · Cited by 143
“It corresponds to 2 main genetic entities: a) type 2A hemochromatosis is due to mutations of the hemojuvelin gene on chromosome 1,(46) a common mutation being G320V; b) type 2B is due to mutations of the hepcidin (HAMP) gene on chromosome 19.(47)”
BackgroundSystemic iron homeostasis and erythropoiesis
Papanikolaou, G. V., & Pantopoulos, K. (2017) · IUBMB Life · doi:10.1002/iub.1629 · Cited by 145
“Thus, inactivating mutations of the hepcidin gene (HAMP) cause juvenile hemochromatosis, a rare, early onset form of HH (48).”
BackgroundSelf-citationPietrangelo, A. (2004) · Hepatology · doi:10.1002/hep.20007 · Cited by 138
Iron, anemia and hepcidin in malaria
Spottiswoode, N., Duffy, P. E., & Drakesmith, H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00125 · Cited by 127
Gangat, N., & Wolanskyj, A. P. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.06.006 · Cited by 133
“In juvenile hemochromatosis, mutations in either HJV or HAMP occur, which results in low hepcidin levels.(16,17) The increase in hepcidin production in response to inflammation is a protective mechanism in the case of infections in which iron restriction would limit bacterial growth.”
BackgroundManipulation of the hepcidin pathway for therapeutic purposes
Fung, E., & Nemeth, E. (2013) · Haematologica · doi:10.3324/haematol.2013.084624 · Cited by 137
Membrane-Anchored Serine Proteases in Vertebrate Cell and Developmental Biology
Szabo, R., & Bugge, T. H. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154247 · Cited by 133
“…bone morphogenetic protein (BMP)6, which signals through BMP receptors and SMAD proteins to stimulate hepcidin gene (HAMP) transcription (Figure 5; Andriopoulos et al. 2009, Babitt et al. 2006, Huang et al. 2005, Meynard et al. 2009, Niederkofler et al. 2005, Roetto et al. 2003, Wang et al. 2005).”
BackgroundDistribution of the iron‐regulating protein hepcidin in the murine central nervous system
Zechel, S., Huber‐Wittmer, K., & Halbach, O. V. B. U. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20991 · Cited by 129
“In humans, mutations of hepcidin cause a severe hereditary juvenile hemochromatosis (Roetto, 2003).”
BackgroundGac, G. L., Scotet, V., Ka, C., Gourlaouen, I., Bryckaert, L., Jacolot, S., Mura, C., & Férec, C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh206 · Cited by 130
“encodes hemojuvelin (4), and in HAMP [OMIM 606464], that encodes hepcidin ( 5 ).”
BackgroundHepcidin antagonists for potential treatments of disorders with hepcidin excess
Poli, M., Asperti, M., Ruzzenenti, P., Regoni, M., & Arosio, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00086 · Cited by 124
“REVIEW ARTICLE published: 28 April 2014 doi: 10.3389/fphar.2014.00086 Hepcidin antagonists for potential treatments of disorders with hepcidin excess”
BackgroundInfluentialSMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression
Mleczko‐Sanecka, K., Casanovas, G., Ragab, A., Breitkopf, K., Müller, A., Boutros, M., Dooley, S., Hentze, M. W., & Muckenthaler, M. U. (2009) · Blood · doi:10.1182/blood-2009-09-238105 · Cited by 133
Functional differences between hepcidin 1 and 2 in transgenic mice
Lou, D.-Q., Nicolas, G., Lesbordes, J.-C., Viatte, L., Grimber, G., Szajnert, M.-F., Kahn, A., & Vaulont, S. (2004) · Blood · doi:10.1182/blood-2003-07-2524 · Cited by 123
Molecular evolution and characterization of hepcidin gene products in vertebrates
Hilton, K. B., & Lambert, L. A. (2008) · Gene · doi:10.1016/j.gene.2008.02.016 · Cited by 132
Normal iron metabolism and the pathophysiology of iron overload disorders.
Siah, C. W., Ombiga, J., Adams, L. A., Trinder, D., & Olynyk, J. K. (2006) · PubMed · Cited by 167
Latour, C., Kautz, L., Besson-Fournier, C., Island, M.-L., Canonne-Hergaux, F., Loréal, O., Ganz, T., Coppin, H., & Roth, M.-P. (2014) · Hepatology · doi:10.1002/hep.26648 · Cited by 120
“In humans, loss-of-function mutations in the hepcidin gene HAMP cause juvenile hemochromatosis, an autosomal recessive disorder characterized by severe iron deposition in multiple organs, including the liver, heart, and endocrine tissues.(5) Recent advances have been made in our understanding of the molecular mechanis…”
BackgroundMolecular pathogenesis of anemia of chronic disease
Ganz, T. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20656 · Cited by 138
“Hepcidin is essential for normal iron homeostasis [16,17] and hepcidin deficiency [17–22] is the main cause of hereditary hemochromatosis, a disease in which iron absorption and release from stores are dysregulated.”
BackgroundSaito, H. (2014) · Institutional Repositories DataBase (IRDB) · doi:10.18999/nagjms.76.3-4.235 · Cited by 160
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Swinkels, D. W., Janssen, M. C. H., Bergmans, J., & Marx, J. J. M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068684 · Cited by 134
Iron and hepcidin: a story of recycling and balance
Camaschella, C. (2013) · Hematology · doi:10.1182/asheducation-2013.1.1 · Cited by 112
Self-citationHepcidin in human iron disorders: Therapeutic implications
Pietrangelo, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.004 · Cited by 126
“Human HC has been associated with the common C282Y polymorphism of HFE [71] or rare pathogenic mutations of TfR2,[72] HJV [40], FPN [73] and HAMP itself [74].”
Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis
Core, A. B., Canali, S., & Babitt, J. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00104 · Cited by 106
Hepcidin Signaling in Health and Disease: Ironing Out the Details
Kowdley, K. V., Gochanour, E. M., Sundaram, V., Shah, R. A., & Handa, P. (2021) · Hepatology Communications · doi:10.1002/hep4.1717 · Cited by 123
Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein
Healey, E. G., Bishop, B., Elegheert, J., Bell, C. H., Padilla-Parra, S., & Siebold, C. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3016 · Cited by 112
Hepcidin--the iron regulatory hormone.
Rossi, E. (2005) · Europe PMC (PubMed Central) · Cited by 112
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
Coffey, R., & Ganz, T. (2018) · HemaSphere · doi:10.1097/hs9.0000000000000035 · Cited by 125
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload
Barisani, D., Pelucchi, S., Mariani, R., Galimberti, S., Trombini, P., Fumagalli, D., Meneveri, R., Nemeth, E., Ganz, T., & Piperno, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.011 · Cited by 120
“The discovery of key new genes and proteins has led to the molecular characterization of forms of primary iron overload caused by mutations of HFE [1], hemojuvelin and HAMP (hepcidin) [2,3] Transferrin Receptor 2 (TfR2) [4] and ferroportin (FP) [5].”
BackgroundBeutler, E. (2003) · Blood · doi:10.1182/blood-2002-06-1747 · Cited by 121
Molecular control of iron metabolism
Andrews, N. C. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.10.004 · Cited by 128
Intravenous iron: From anathema to standard of care
Auerbach, M., Coyne, D., & Ballard, H. S. (2008) · American Journal of Hematology · doi:10.1002/ajh.21154 · Cited by 115
“A recently identified gene, hemojuvulin, may act in concert with hepcidin to induce these changes [59].”
BackgroundFrazer, D. M., Inglis, H. R., Wilkins, S. J., Millard, K. N., Steele, T. M., McLaren, G. D., McKie, A. T., Vulpe, C. D., & Anderson, G. J. (2004) · Gut · doi:10.1136/gut.2003.037416 · Cited by 109
Current Approaches to the Management of Hemochromatosis
Brissot, P., & BELS, F. D. (2006) · Hematology · doi:10.1182/asheducation-2006.1.36 · Cited by 113
Kato, A., Tsuji, T., Luo, J., Sakao, Y., Yasuda, H., & Hishida, A. (2007) · American Journal of Nephrology · doi:10.1159/000109968 · Cited by 115
“In humans, mutations of the hepcidin gene are known to be implied in a severe iron overload disease such as juvenile hemochromatosis [”
BackgroundProbiotics in inflammatory bowel disease: is it all gut flora modulation?: Figure 1
Ghosh, S. K., van Heel, D. A., & Playford, R. J. (2004) · Gut · doi:10.1136/gut.2003.034249 · Cited by 113
Gender-related variations in iron metabolism and liver diseases
Harrison-Findik, D. D. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i8.302 · Cited by 109
Pietrangelo, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.013 · Cited by 140
Mitochondrial involvement in genetically determined transition metal toxicity
Mehta, R., Templeton, D. M., & O'Brien, P. J. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.05.011 · Cited by 115
Knisely, A. S., Mieli‐Vergani, G., & Whitington, P. F. (2003) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(03)00050-5 · Cited by 104
Iron metabolism: current facts and future decisions
Tandara, L., & Salamunić, I. (2012) · Biochemia Medica · doi:10.11613/bm.2012.034 · Cited by 120
Johnson, M. B., Chen, J., Murchison, N., Green, F. A., & Enns, C. A. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-09-0798 · Cited by 112
“Because TfR2 is expressed in hepatocytes, it is positioned to regulate the expression of hepcidin, a small peptide hormone synthesized and secreted by hepatocytes that controls systemic iron levels by modulating cellular iron efflux (Nicolas et al., 2001, 2002; Pigeon et al., 2001; Roetto et al., 2003; Nemeth et al.,…”
BackgroundInherited Disorders of Iron Overload
Pantopoulos, K. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00103 · Cited by 116
“Subsequent work demonstrated that the relatively more predominant 1q-linked form of juvenile hemochromatosis (subtype 2A; OMIM #602390) is caused by inactivation of the HJV gene encoding hemojuvelin that severely suppresses hepcidin expression (71), while the 1qunlinked form (subtype 2B; OMIM #613313) is directly caus…”
BackgroundWallace, D. F. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4690 · Cited by 101
Hepcidin, the Recently Identified Peptide that Appears to Regulate Iron Absorption
Leong, W.-I., & Lönnerdal, B. L. (2004) · Journal of Nutrition · doi:10.1093/jn/134.1.1 · Cited by 115
The Ins and Outs of Iron Homeostasis
Donovan, A., Roy, C. N., & Andrews, N. C. (2006) · Physiology · doi:10.1152/physiol.00052.2005 · Cited by 98
Troutt, J. S., Rudling, M., Persson, L., Ståhle, L., Angelin, B., Butterfield, A. M., Schade, A. E., Cao, G., & Konrad, R. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.186866 · Cited by 100
Iron overload in the Asian community
Lok, C. Y., Merryweather‐Clarke, A. T., Viprakasit, V., Chinthammitr, Y., Srichairatanakool, S., Limwongse, C., Oleesky, D. A., Robins, A. J., Hudson, J., Wai, P. T. J., et al. (2009) · Blood · doi:10.1182/blood-2009-01-199109 · Cited by 100
Małyszko, J., Małyszko, J. S., Pawlak, K., & Myśliwiec, M. (2006) · American Journal of Hematology · doi:10.1002/ajh.20657 · Cited by 107
“Institution of an iron-free diet, production of the anemic state, and hypoxia are associated with decreased hepcidin production, while increased hepcidin production is noted in acute inflammation [16,17].”
BackgroundHsieh, J.-C., Pan, C., & Chen, J. (2010) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.05.001 · Cited by 105
“Overexpression of hepcidin from hepatic adenomas was found in a patient with refractory anemia, and mutations in the hepcidin gene were present in severe cases of juvenile hemochromatosis (JH) [6,7].”
BackgroundIlyin, G., Courselaud, B., Troadec, M.-B., Pigeon, C., Alizadeh, M., Leroyer, P., Brissot, P., & Loréal, O. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00329-6 · Cited by 99
Wang, X., Zhang, M., Flores, S. R. L., Woloshun, R. R., Yang, C., Yin, L., Xiang, P., Xu, X., Garrick, M. D., Vidyasagar, S., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.003 · Cited by 99
“, juvenile) iron loading in humans.(13) Although mutations in Hamp (encoding hepcidin) represent a rare cause of HH in humans,(14) observations in this most severe ironloading condition should be applicable to other (less severe) forms of the disease.”
BackgroundPietrangelo, A., Caleffi, A., & Corradini, E. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1286061 · Cited by 107
“The study of additional cases with JHC identified a cohort demonstrating mutations in HAMP, the gene encoding hepcidin, on chromosome 19q13.(7)HAMP-HC is much rarer than HJV-HC, and only few cases have been reported so far.”
BackgroundWallace, D. F., & Subramaniam, V. N. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.140 · Cited by 115
Xu, Y., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · British Journal of Haematology · doi:10.1111/bjh.17252 · Cited by 103
Hepcidin in Anemia and Inflammation in Chronic Kidney Disease
Małyszko, J., & Myśliwiec, M. (2007) · Kidney & Blood Pressure Research · doi:10.1159/000098522 · Cited by 111
Metadata
- Authors
- Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- National and Kapodistrian University of Athens (GR)
- University of Verona (IT)
- Theageneio General Hospital (GR)
- Corresponding author
- Camaschella, Clara
- ORCID
- Venue
- Nature Genetics
- Published
- 2002-12-09
- Volume
- 33
- Issue
- 1
- Pages
- 21-22
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2056282179
- Cited by
- 860
- References
- 16
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 23 · 2019: 14 · 2018: 19 · 2017: 35 · 2016: 23 · 2015: 32 · 2014: 28 · 2013: 37 · 2012: 37
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- hepcidin, juvenile hemochromatosis, antimicrobial peptides, iron absorption regulation, 19q13, hereditary hemochromatosis
- MeSH terms
- Amino Acid Sequence, Base Sequence, Child, DNA Mutational Analysis, Female, Hemochromatosis, Humans, Male, Molecular Sequence Data, Mutation, Pedigree, Polymorphism, Single-Stranded Conformational, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.